A University of Houston biomedical engineer and his team are reporting the discovery of new biomarkers for early detection of bladder cancer (BC), among the most common cancers diagnosed in men in the U.S.
Since the beginning of the year, Derek Smith has been pursuing his position as Interim Chief Commercial Officer at Optimer® binders developer Aptamer Group. Click to read more.
10 January 2023 Aptamer Group plc("Aptamer", the "Company" or the "Group") Appointment of Interim Chief Commercial Officer Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders